Beone Medicines
Clinical trials sponsored by Beone Medicines, explained in plain language.
-
Can a new pill outsmart RAS-Mutant cancers?
Disease control Not yet recruitingThis early-stage trial is testing an experimental oral drug called BG-85738 in people with advanced or metastatic solid tumors that have RAS mutations. The study aims to see if the drug is safe and tolerable when given alone or combined with other anti-cancer agents, and to get a…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a flexible dosing schedule improve esophageal cancer treatment?
Disease control Not yet recruitingThis phase 2 trial is testing whether giving the immunotherapy drug tislelizumab every 2 weeks or every 4 weeks, alongside standard chemotherapy, is safe and effective for Japanese patients with advanced esophageal cancer that cannot be removed by surgery. The study aims to find …
Phase: PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC